Website
News25/Ratings4
Latest news
25 items- SECSEC Form 15-12B filed by Itamar Medical Ltd.15-12B - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form EFFECT filed by Itamar Medical Ltd.EFFECT - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form EFFECT filed by Itamar Medical Ltd.EFFECT - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form POS AM filed by Itamar Medical Ltd.POS AM - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form POS AM filed by Itamar Medical Ltd.POS AM - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form S-8 POS filed by Itamar Medical Ltd.S-8 POS - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form S-8 POS filed by Itamar Medical Ltd.S-8 POS - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 25-NSE filed by Itamar Medical Ltd.25-NSE - Itamar Medical Ltd. (0001613170) (Subject)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- PRItamar Medical Reports Third Quarter 2021 Financial Results- Revenues Increased 23% Year-over-Year to $13.6 Million - - U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million - CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results for the third quarter of 2021. "Third quarter results represent the strong traction our WatchPAT™ platform technology has gained entering the second half of 2021. Growth in the U.S. continues to outpace our overall growth on top of expanding adoption in the markets we serve thr
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- 13D/GSEC Form SC 13G/A filed by Itamar Medical Ltd. (Amendment)SC 13G/A - Itamar Medical Ltd. (0001613170) (Subject)
- ANALYSTItamar Medical downgraded by SVB Leerink with a new price targetSVB Leerink downgraded Itamar Medical from Outperform to Market Perform and set a new price target of $31.00 from $30.00 previously
- ANALYSTItamar Medical downgraded by Ladenburg Thalmann with a new price targetLadenburg Thalmann downgraded Itamar Medical from Buy to Neutral and set a new price target of $33.85
- ANALYSTItamar Medical downgraded by HC Wainwright & Co. with a new price targetHC Wainwright & Co. downgraded Itamar Medical from Buy to Neutral and set a new price target of $31.00 from $36.00 previously
- ANALYSTItamar Medical downgraded by Cowen & Co. with a new price targetCowen & Co. downgraded Itamar Medical from Outperform to Market Perform and set a new price target of $31.00 from $30.00 previously
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K/A filed by Itamar Medical Ltd. (Amendment)6-K/A - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)